Literature DB >> 16199038

Approaches for chemically synthesized siRNA and vector-mediated RNAi.

Mohammed Amarzguioui1, John J Rossi, Dongho Kim.   

Abstract

Successful applications of RNAi in mammalian cells depend upon effective knockdown of targeted transcripts and efficient intracellular delivery of either preformed si/shRNAs or vector expressed si/shRNAs. We have previously demonstrated that 27 base pair double stranded RNAs which are substrates for Dicer can be up to 100 times more potent than 21mer siRNAs. In this mini-review we elaborate upon the rationale and design strategies for creating Dicer substrate RNAs that provide enhanced knockdown of targeted RNAs and minimize the utilization of the sense strand as RNAi effectors. Expression of shRNAs or siRNAs in mammalian cells can be achieved via transcription from either Pol II or Pol III promoters. There are certain constrictions in designing such vectors, and these are described here. Additionally, we review strategies for inducible shRNA expression and the various viral vectors that can be used to transduce shRNA genes into a variety of cells and tissues. The overall goal of this mini-review is to provide an overview of available approaches for optimizing RNAi mediated down regulation of gene expression in mammalian cells via RNA interference. Although the primary focus is the use of RNAi mediated cleavage of targeted transcripts, it is highly probable that some of the approaches described herein will be applicable to RNAi mediated inhibition of translation and transcriptional gene silencing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199038     DOI: 10.1016/j.febslet.2005.08.070

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  58 in total

Review 1.  Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.

Authors:  Saurabh Singh; Ajit S Narang; Ram I Mahato
Journal:  Pharm Res       Date:  2011-10-28       Impact factor: 4.200

Review 2.  Antiviral silencing in animals.

Authors:  Hong-Wei Li; Shou-Wei Ding
Journal:  FEBS Lett       Date:  2005-08-31       Impact factor: 4.124

3.  Large-scale production of dsRNA and siRNA pools for RNA interference utilizing bacteriophage phi6 RNA-dependent RNA polymerase.

Authors:  Antti P Aalto; L Peter Sarin; Alberdina A van Dijk; Mart Saarma; Minna M Poranen; Urmas Arumäe; Dennis H Bamford
Journal:  RNA       Date:  2007-01-19       Impact factor: 4.942

4.  Two approaches to construct mammalian expression vector of shRNA to reduce expression and replication of HBV in vitro.

Authors:  Hong-Bin Zhang; Jie Wu; Jiang Xian; Lei Pei; Jie Wang
Journal:  Mol Biol Rep       Date:  2007-06-22       Impact factor: 2.316

5.  Sensitive detection of GFP utilizing tyramide signal amplification to overcome gene silencing.

Authors:  Zsuzsanna E Toth; Tal Shahar; Ronen Leker; Ildiko Szalayova; András Bratincsák; Sharon Key; Anna Lonyai; Krisztián Németh; Eva Mezey
Journal:  Exp Cell Res       Date:  2007-03-12       Impact factor: 3.905

Review 6.  Emergence of a complex relationship between HIV-1 and the microRNA pathway.

Authors:  Dominique L Ouellet; Isabelle Plante; Corinne Barat; Michel J Tremblay; Patrick Provost
Journal:  Methods Mol Biol       Date:  2009

7.  RNA interference with special reference to combating viruses of crustacea.

Authors:  Kathy La Fauce; Leigh Owens
Journal:  Indian J Virol       Date:  2012-08-14

Review 8.  Target validation to biomarker development: focus on RNA interference.

Authors:  Riccardo Colombo; Jürgen Moll
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

9.  Using RNA-mediated interference feeding strategy to screen for genes involved in body size regulation in the nematode C. elegans.

Authors:  Jun Liang; Sheng Xiong; Cathy Savage-Dunn
Journal:  J Vis Exp       Date:  2013-02-13       Impact factor: 1.355

Review 10.  Sequence-non-specific effects of RNA interference triggers and microRNA regulators.

Authors:  Marta Olejniczak; Paulina Galka; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2009-10-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.